Completed
The Controversy and Risks of Microdosing Psychedelics
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Non-Hallucinogenic Psychedelics: A New Treatment for Mental Health Disorders
Automatically move to the next video in the Classroom when playback concludes
- 1 Introduction to the Resurgence of Psychedelic Drugs
- 2 The Potential of Psychedelics in Treating Mental Illnesses
- 3 The Role of Neuroscience in Understanding Psychedelics
- 4 The Quest for Psychedelic Drugs Without Hallucinations
- 5 The Global Mental Health Crisis and the Need for New Solutions
- 6 The Promise of Psychedelics in Treating Mental Health Conditions
- 7 The History and Current Resurgence of Psychedelics
- 8 The Challenges and Potential of Psychedelic Research
- 9 The Role of Ketamine in Psychedelic Research
- 10 The Mechanism of Psychedelics in the Brain
- 11 The Risks and Challenges of Psychedelic Use
- 12 The Development of Non-Hallucinogenic Psychedelics
- 13 The Role of the Institute for Psychedelics and Neurotherapeutics
- 14 The Potential of TBG: A Non-Hallucinogenic Psychedelic
- 15 The Controversy and Risks of Microdosing Psychedelics
- 16 Advice for Those Interested in Psychedelic Therapies
- 17 Conclusion and Final Thoughts
